Organogenesis (ORGO) News Today $4.07 -0.06 (-1.45%) As of 11:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORGO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGOOctober 8 at 4:36 PM | prnewswire.com293,029 Shares in Organogenesis $ORGO Acquired by HighMark Wealth Management LLCOctober 3, 2025 | marketbeat.comOrganogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025October 1, 2025 | globenewswire.comOrganogenesis: Mixed ReNu Data, But Policy Tailwinds And Growth Remain BullishSeptember 29, 2025 | seekingalpha.comOrganogenesis (NASDAQ:ORGO) Receives "Buy" Rating from BTIG ResearchSeptember 28, 2025 | americanbankingnews.comOrganogenesis (NASDAQ:ORGO) Shares Down 11.3% - What's Next?September 26, 2025 | marketbeat.comWhy Is Organogenesis Stock Trading Lower Friday?September 26, 2025 | benzinga.comOrganogenesis (NASDAQ:ORGO) Given "Buy" Rating at BTIG ResearchSeptember 26, 2025 | marketbeat.comBuy Rating for Organogenesis Holdings Despite Mixed Trial Results, Supported by Diversified Revenue and FDA Clearance EffortsSeptember 26, 2025 | tipranks.comOrganogenesis provides update on second Phase 3 ReNu studySeptember 25, 2025 | msn.comOrganogenesis Provides Update on Second Phase 3 ReNu® StudySeptember 25, 2025 | finance.yahoo.comOrganogenesis stock falls after knee osteoarthritis trial misses endpointSeptember 25, 2025 | za.investing.comOrganogenesis Holdings Faces Setback in ReNu Phase 3 TrialSeptember 25, 2025 | tipranks.comOrganogenesis Holdings Inc. Announced Results from Second Phase 3 Trial of ReNu for Knee Osteoarthritis Pain ManagementSeptember 25, 2025 | quiverquant.comQOrganogenesis Provides Update on Second Phase 3 ReNu® StudySeptember 25, 2025 | globenewswire.comAssenagon Asset Management S.A. Buys 2,520,941 Shares of Organogenesis $ORGOSeptember 24, 2025 | marketbeat.comAcadian Asset Management LLC Cuts Stake in Organogenesis $ORGOSeptember 15, 2025 | marketbeat.comBuy Rating for Organogenesis Holdings Amid Favorable Medicare Pricing and Market PositioningSeptember 10, 2025 | tipranks.comTrexquant Investment LP Invests $516,000 in Organogenesis $ORGOSeptember 10, 2025 | marketbeat.comNuveen LLC Purchases New Shares in Organogenesis $ORGOSeptember 4, 2025 | marketbeat.comDriehaus Capital Management LLC Makes New Investment in Organogenesis $ORGOSeptember 2, 2025 | marketbeat.com123,131 Shares in Organogenesis $ORGO Purchased by Russell Investments Group Ltd.September 2, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Trims Position in Organogenesis $ORGOSeptember 1, 2025 | marketbeat.comVanguard Group Inc. Purchases 841,618 Shares of Organogenesis $ORGOSeptember 1, 2025 | marketbeat.comOrganogenesis: Transformational Changes Taking ShapeAugust 31, 2025 | seekingalpha.comInvesco Ltd. Acquires 947,705 Shares of Organogenesis $ORGOAugust 31, 2025 | marketbeat.comOrganogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in SeptemberAugust 27, 2025 | globenewswire.comVirtus Advisers LLC Takes $425,000 Position in Organogenesis $ORGOAugust 27, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.August 16, 2025 | marketbeat.comOrganogenesis Holdings’ Earnings Call: Mixed Sentiments and Strategic MovesAugust 13, 2025 | msn.comOrganogenesis (NASDAQ:ORGO) Issues Earnings Results, Misses Expectations By $0.08 EPSAugust 11, 2025 | marketbeat.comOrganogenesis Amends Credit Agreement Amid Revenue DeclineAugust 11, 2025 | theglobeandmail.comOrganogenesis (NASDAQ:ORGO) Shares Gap Down - Here's What HappenedAugust 9, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Price Target Raised to $9.00 at Cantor FitzgeraldAugust 9, 2025 | marketbeat.comORGO Sales Drop 23%August 9, 2025 | theglobeandmail.comOrganogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comOrganogenesis Holdings Inc (ORGO) Q2 2025 Earnings Call Highlights: Navigating Market ...August 8, 2025 | gurufocus.comOrganogenesis Holdings Inc. Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comUniversal Beteiligungs und Servicegesellschaft mbH Buys Shares of 146,065 Organogenesis (NASDAQ:ORGO)August 3, 2025 | marketbeat.comOrganogenesis (ORGO) to Release Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comOrganogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025July 22, 2025 | globenewswire.comCMS Proposes Overhaul to Medicare Payment System to Curb Costs and Enhance CareJuly 20, 2025 | msn.comOrganogenesis (NASDAQ:ORGO) Trading Up 5.8% - Still a Buy?July 16, 2025 | marketbeat.comMiMedx and Organogenesis stocks tumble after CMS proposal to slash spendingJuly 16, 2025 | finance.yahoo.comOrganogenesis (NASDAQ:ORGO) Shares Gap Down - Here's WhyJuly 15, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Receives Overweight Rating from Cantor FitzgeraldJuly 15, 2025 | marketbeat.comOrganogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued InnovationJuly 15, 2025 | globenewswire.comOrganogenesis (NASDAQ:ORGO) Shares Gap Up - Here's What HappenedJuly 8, 2025 | marketbeat.comOrganogenesis Holdings Inc. (ORGO) - Yahoo FinanceJuly 4, 2025 | finance.yahoo.comOrganogenesis (NASDAQ:ORGO) Stock Price Up 7.4% - Should You Buy?July 3, 2025 | marketbeat.com Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORGO Media Mentions By Week ORGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGO News Sentiment▼0.630.63▲Average Medical News Sentiment ORGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGO Articles This Week▼33▲ORGO Articles Average Week Get the Latest News and Ratings for ORGO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Organogenesis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Intellia Therapeutics News Ocular Therapeutix News ANI Pharmaceuticals News Vera Therapeutics News Twist Bioscience News Dyne Therapeutics News Apogee Therapeutics News Cogent Biosciences News Tilray Brands News AbCellera Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Please log in to your account or sign up in order to add this asset to your watchlist. Share Organogenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
